Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Oxalo Therapeutics Logo
Oxalo Therapeutics Growth Score
49
CB Rank
121221
Heat Score
32
Oxalo Therapeutics creates drugs to treat rare kidney diseases and prevent recurring kidney stones.
Founded
obfuscation
PrivateGrant Chicago, Illinois, United States1-10 www.oxalotherapeutics.com/
Biotechnology
Clinical Trials
Medical
Therapeutics
Overview

Oxalo Therapeutics
Total Funding
obfuscation
Growth Score
49
Heat Score
32

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score49
-2 pts
in past quarter
Heat Score 32
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Oxalo Therapeutics

CB Rank
121221
Oxalo Therapeutics creates drugs to treat rare kidney diseases and prevent recurring kidney stones.
Founded
obfuscation
PrivateGrant Chicago, Illinois, United States1-10 www.oxalotherapeutics.com/
Biotechnology
Clinical Trials
Medical
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Oxalo Therapeutics, Inc.
Operating Status Active
Company Type For Profit
Founders  Hatim Hassan, Yang Zheng
About the Company

Oxalo Therapeutics creates drugs to treat rare kidney diseases and prevent recurring kidney stones. Oxalo Therapeutics is tackling primary hyperoxaluria and other oxalate pathologies. Oxalo Therapeutics develops innovative therapies by leveraging its expertise in the microbiome, translational research, and early-stage technology commercialization.

Oxalo's method mimics a natural mechanism for safely removing oxalate from the body, thereby preventing recurrent kidney stones and other oxalate pathologies.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

OFX-514
An oral peptide-based therapeutic designed to stimulate intestinal oxalate secretion to reduce plasma and urine oxalate levels.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
1
obfuscation
National Science FoundationGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
1
obfuscation
National Science FoundationGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
National Science Foundation Logo
National Science Foundation
Yes
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Oxalo Therapeutics Logo
Grant - Oxalo Therapeutics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News

News and Press

News•Dec 31, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

161

IT Spend

$104.4KThis year, Oxalo Therapeutics is projected to spend $104.4K on IT, according to Aberdeen.

Active Website Tech Count

3Oxalo Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Oxalo Therapeutics's headquarters? Oxalo Therapeutics is located in Chicago, Illinois, United States.Who invested in Oxalo Therapeutics? Oxalo Therapeutics has 4 investors including National Science Foundation and  National Science Foundation.When was the last funding round for Oxalo Therapeutics? Oxalo Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are Oxalo Therapeutics's competitors? Alternatives and possible competitors to Oxalo Therapeutics may include Alnylam Pharmaceuticals, Novo Nordisk, and  Baxter International.How much funding has Oxalo Therapeutics raised to date? Oxalo Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8c8a01a 1)
|